| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $934.8M | — | +2.6% |
| Cost of Revenue | $648.5M | — | +1.5% |
| R&D Expense | $31.9M | — | -13.3% |
| SG&A Expense | $93.4M | — | +8.6% |
| Operating Income | $141.6M | — | +15.9% |
| Pre-tax Income | $115.5M | — | +27.4% |
| Income Tax | $28.4M | — | +37.1% |
| Net Income | $87.1M | — | +24.6% |
| EPS (Basic) | $0.60 | — | +27.7% |
| EPS (Diluted) | $0.59 | — | +25.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $635.1M | +10.8% | +8.0% |
| Accounts Receivable | $693.2M | +5.4% | -0.3% |
| Inventory | $605.8M | -1.9% | -8.4% |
| Current Assets | $2.09B | +4.6% | -0.6% |
| Total Assets | $6.82B | +0.9% | -5.0% |
| Current Liabilities | $758.6M | -2.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $122.5M | — | +2.8% |
| Investing Cash Flow | -$16.5M | — | -140.0% |
| Financing Cash Flow | -$44.7M | — | +62.5% |
| -4.4% |
| Long-term Debt | $2.83B | -0.6% | -10.9% |
| Total Liabilities | $3.96B | -0.2% | -8.5% |
| Stockholders' Equity | $2.86B | +2.5% | +0.2% |